Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs Intranasal Oxytocin on Attention Control
NCT04815395Completed
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Dec 2017
- Primary completion
- Jan 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin (3 arms), sponsored by University of Electronic Science and Technology of China. Primary endpoints: Differential effects of intranasal and oral oxytocin administration on saccade/antisaccade latencies towards social (facial) versus non-social (shape) stimuli and Differential effects of intranasal and oral oxytocin administration on error rates of saccade/antisaccade for social (facial) versus non-social (shape) stimuli. Started Dec 2017; status: completed.
02
Drugs
oxytocin
Beyond the preview
Go deeper on NCT04815395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04815395.